ONCY
Oncolytics Biotech
ONCY
ONCY
33 hedge funds and large institutions have $13.6M invested in Oncolytics Biotech in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 32 → 33 (+1)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.6M | |
| 2 | +$464K | |
| 3 | +$47K | |
| 4 |
AFP
Ausdal Financial Partners
Davenport,
Iowa
|
+$43.6K |
| 5 |
BAM
Brave Asset Management
Summit,
New Jersey
|
+$33K |
Top Sellers
| 1 | -$265K | |
| 2 | -$100K | |
| 3 | -$49.2K | |
| 4 |
DI
Disciplined Investments
Tulsa,
Oklahoma
|
-$13.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.6K |